MRK Merck & Co., Inc. Stock Quote

MRK [NYSE]

Healthcare | Drug Manufacturers - General | USA

Index	DJIA S&P500	P/E	17.26	EPS (ttm)	5.48	Insider Own	0.10%	Shs Outstand	2.53B	Perf Week	1.76%
Market Cap	235.59B	Forward P/E	12.90	EPS next Y	7.34	Insider Trans	0.00%	Shs Float	2.53B	Perf Month	10.77%
Income	13.91B	PEG	1.48	EPS next Q	1.69	Inst Own	75.20%	Short Float	0.67%	Perf Quarter	24.79%
Sales	53.98B	P/S	4.36	EPS this Y	173.50%	Inst Trans	0.30%	Short Ratio	1.49	Perf Half Y	15.92%
Book/sh	16.17	P/B	5.85	EPS next Y	-0.15%	ROA	14.30%	Target Price	96.54	Perf Year	28.07%
Cash/sh	3.59	P/C	26.39	EPS next 5Y	11.62%	ROE	38.30%	52W Range	70.89 - 94.92	Perf YTD	23.49%
Dividend	2.76	P/FCF	38.81	EPS past 5Y	28.20%	ROI	15.50%	52W High	-0.43%	Beta	0.35
Dividend %	2.92%	Quick Ratio	1.10	Sales past 5Y	4.10%	Gross Margin	71.10%	52W Low	33.32%	ATR	1.97
Employees	68000	Current Ratio	1.40	Sales Q/Q	49.60%	Oper. Margin	28.90%	RSI (14)	73.08	Volatility	1.63% 2.31%
Optionable	Yes	Debt/Eq	0.78	EPS Q/Q	57.20%	Profit Margin	26.30%	Rel Volume	0.60	Prev Close	94.64
Shortable	Yes	LT Debt/Eq	0.75	Earnings	Apr 28 BMO	Payout	47.80%	Avg Volume	11.41M	Price	94.51
Recom	2.20	SMA20	5.08%	SMA50	10.02%	SMA200	17.97%	Volume	478,791	Change	-0.14%

Apr-06-22

Resumed

Morgan Stanley

Equal-Weight

$80

Dec-17-21

Initiated

Goldman

Buy

$93

Dec-16-21

Initiated

Daiwa Securities

Neutral

$70

Dec-13-21

Downgrade

UBS

Buy → Neutral

$98 → $76

Dec-09-21

Initiated

Wells Fargo

Overweight

$90

Dec-07-21

Downgrade

Guggenheim

Buy → Neutral

Nov-29-21

Downgrade

Citigroup

Buy → Neutral

$105 → $85

Nov-19-21

Initiated

BMO Capital Markets

Market Perform

$91

Nov-01-21

Upgrade

Argus

Hold → Buy

$110

Sep-07-21

Downgrade

Morgan Stanley

Overweight → Equal-Weight

$85

Jul-27-21

Resumed

Truist

Buy

$92

May-20-21

Downgrade

Argus

Buy → Hold

Apr-07-21

Resumed

RBC Capital Mkts

Sector Perform

$79

Nov-10-20

Resumed

Bernstein

Outperform

$95

Sep-29-20

Initiated

Berenberg

Hold

$88

Aug-03-20

Upgrade

Goldman

Neutral → Buy

$91 → $105

Jun-12-20

Downgrade

Wolfe Research

Outperform → Peer Perform

Feb-27-20

Initiated

Barclays

Overweight

$93

Jan-07-20

Initiated

RBC Capital Mkts

Sector Perform

$99

Oct-17-19

Resumed

BofA/Merrill

Neutral

$90

May-24-22 01:46PM	Merck Announces Third-Quarter 2022 Dividend Business Wire
09:56AM	How Our OneTen Pilot Program Paved the Way for Hiring Diverse Talent News Direct
06:45AM	European Commission Approves KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced or Early-Stage Triple-Negative Breast Cancer at High Risk of Recurrence Business Wire
May-23-22 10:14AM	Merck's (MRK) Keytruda Gets CHMP Nod for Expanded Melanoma Use Zacks
May-21-22 11:00AM	7 Quality Dividend Stocks to Buy on the Dip InvestorPlace
07:31AM	7 Retirement Stocks to Buy for Any Market Conditions InvestorPlace
May-20-22 02:56PM	CHMP Supports Approval Of Merck's Keytruda As Adjuvant In Post Surgery Melanoma Setting Benzinga
02:17PM	Mirati (MRTX) Seeks EU Nod for Adagrasib to Treat Lung Cancer Zacks
09:39AM	Nomura now expects the Fed to hike interest rates by 75 points in June and July here are 3 stocks to help protect your wealth this summer MoneyWise
09:25AM	Zacks Industry Outlook Highlights Eli Lilly, Novo Nordisk, Merck, and Glaxo Zacks
08:15AM	Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Adolescent (12 Years of Age) Patients With Stage IIB or IIC Melanoma Following Complete Resection Business Wire
May-19-22 02:47PM	Antibiotic resistance efforts get a boost as CARB-X gets $370M American City Business Journals
09:32AM	4 Large Drug Stocks to Watch as the Industry Recovers Zacks
09:00AM	12 Best DOW Stocks To Buy According To Hedge Funds Insider Monkey
08:31AM	Merck (MRK) Outperforms Industry This Year So Far: Here's Why Zacks
07:43AM	7 Dividend Stocks to Boost Your Retirement Savings InvestorPlace
May-18-22 10:07AM	Pfizer (PFE) Gets EUA for Use of Comirnaty Booster in Children Zacks
May-17-22 11:58AM	Buffetts Berkshire Hathaway is buying up Chevron, Citigroup, Paramount stocks Yahoo Finance Video
May-16-22 12:46PM	Celebrating Our Asian American and Pacific Islander Colleagues News Direct
06:00AM	7 Retirement Stocks for Steady Long-Term Income Growth InvestorPlace
May-12-22 10:00AM	Generic drugmakers to sell Pfizer's Paxlovid for $25 or less in low-income countries Reuters
02:00AM	RPT-New class of cancer drugs down, not out, after Roche trial setback - analysts Reuters
May-11-22 02:28PM	New class of cancer drugs down, not out, after Roche trial setback - analysts Reuters
08:59AM	10 Stocks to Invest in Under $20 According to Michael Castors Sio Capital Insider Monkey
May-10-22 06:45AM	Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab) Business Wire
May-09-22 09:22AM	Investors in Merck (NYSE:MRK) have made a respectable return of 70% over the past five years Simply Wall St.
May-06-22 09:40AM	Why Merck (MRK) is a Top Value Stock for the Long-Term Zacks
May-05-22 08:33PM	Dow Jones Futures: Stocks Plunge As Treasury Yields Soar In Delayed Fed Reaction Investor's Business Daily
May-04-22 11:39AM	Moderna (MRNA) Beats on Q1 Earnings, to Start Two Late Studies Zacks
11:23AM	Warren Buffett Stocks: What's Inside Berkshire Hathaway's Portfolio? Investor's Business Daily
06:45AM	Merck to Participate in Bank of America Securities 2022 Healthcare Conference Business Wire
May-03-22 09:53AM	Dow Jones Falls Ahead Of Fed Meeting; 7 Key Earnings Movers Investor's Business Daily
May-02-22 02:16PM	The Gift of Caring for Aging Parents News Direct
09:48AM	Pfizer COVID-19 pill fails as preventive therapy in trial Yahoo Finance Video
06:15AM	7 Safe Stocks to Buy in May 2022 InvestorPlace
Apr-29-22 11:30AM	What This Regulatory News Could Mean for Merck Motley Fool
10:32AM	Pharma Stock Roundup: Q1 Earnings of LLY, MRK & NVS, FDA Updates for AZN & PFE Zacks
09:34AM	Company News for Apr 29, 2022 Zacks
06:45AM	European Commission Approves Mercks KEYTRUDA® (pembrolizumab) for Patients With Microsatellite Instability-High (MSI-H) or Deficient Mismatch Repair (dMMR) Tumors in Five Different Types of Cancer Business Wire
06:30AM	European Commission Approves Mercks KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS 1) Business Wire
Apr-28-22 05:21PM	IBD Stock Of The Day Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion Investor's Business Daily
04:26PM	The Pandemics Impact on Merck Is Lessening, CFO Says Barrons.com
03:33PM	COVID-19: Moderna asks FDA to authorize vaccine for young kids, Merck antiviral pill sales top $3B Yahoo Finance Video
12:30PM	Merck & Co. (MRK) Q1 2022 Earnings Call Transcript Motley Fool
12:08PM	Robinhood, Apple, Amazon set to report earnings after the bell Yahoo Finance Video
11:34AM	Merck (MRK) Q1 Earnings & Sales Beat, COVID Drug Adds $3.3B Zacks
10:41AM	Merck Notches Quarterly Beat As Covid Pill Brings In $3.2 Billion In Sales Investor's Business Daily
10:23AM	Could This FDA Approval Be a Boost for Merck? Motley Fool
10:15AM	Stocks today: Tesla lags, Meta jumps, Boeing declines, Pinterest pops Yahoo Finance Video
09:41AM	Merck stock pops on earnings beat, COVID treatment sales Yahoo Finance Video
07:45AM	Merck (MRK) Surpasses Q1 Earnings and Revenue Estimates Zacks
07:02AM	Merck shares pop premarket after earnings beat as COVID antiviral sales top $3 billion MarketWatch
06:41AM	Merck raises 2022 forecast as COVID pill, cancer drug fuels profit beat Reuters
06:30AM	Merck quarterly profit tops expectations on demand for COVID pill, cancer drugs Reuters
06:30AM	Merck Announces First-Quarter 2022 Financial Results Business Wire
Apr-27-22 05:01PM	Former U.S. Surgeon General talks Faucis pandemic comments, COVID vaccines for kids, mask mandates Yahoo Finance Video
02:03PM	Drug/Biotech Stocks Q1 Earnings Due on Apr 28: MRK, LLY & More Zacks
08:40AM	Why Earnings Season Could Be Great for Merck (MRK) Zacks
06:39AM	The Zacks Analyst Blog Highlights Novo Nordisk, Advanced Micro Devices, Netflix, Merck, and Marsh & McLennan Zacks
Apr-26-22 06:23PM	Absci's CEO on what lured the biotech to the Big Apple American City Business Journals
05:20PM	Top Research Reports for Novo Nordisk, AMD & Netflix Zacks
09:31AM	Will Merck (MRK) Beat Expectations This Earnings Season? Zacks
05:50AM	The Zacks Analyst Blog Highlights Amgen, Chevron, Coca-Cola, Visa and Merck Zacks
Apr-25-22 06:45AM	Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Neoadjuvant Treatment, Then Continued as Adjuvant Monotherapy After Surgery for Locally Advanced, or High-Risk Early-Stage Triple-Negative Breast Cancer (TNBC) Business Wire
06:18AM	5 Blue-Chip Stocks Likely to Gain on Earnings Results This Week Zacks
Apr-21-22 03:01PM	Merck (MRK) Earnings Expected to Grow: Should You Buy? Zacks
10:15AM	3 High-Yielding Dividend Stocks You Can Buy and Forget Motley Fool
Apr-20-22 05:45PM	Merck (MRK) Gains As Market Dips: What You Should Know Zacks
11:07AM	2 Healthcare Stocks That Could Make You Richer Motley Fool
09:58AM	Merck: The Vaccine Pioneers News Direct
08:35AM	AstraZeneca's (AZN) Enhertu sBLA Receives FDA Priority Tag Zacks
06:45AM	Merck Announces That Joseph Romanelli Will Lead Merck Human Health International, Effective August 1, 2022 Business Wire
Apr-19-22 11:50AM	Exelixis (EXEL) Outperforms Industry YTD: What Lies Ahead? Zacks
Apr-18-22 10:55AM	Merck's (MRK) Pneumococcal Jab Gets FDA's Breakthrough Tag Zacks
09:32AM	Nektar (NKTR) Ends Bempeg Plus Opdivo Program on Study Failures Zacks
06:59AM	Health Canada Approves KEYTRUDA® (pembrolizumab) for the treatment of adult patients with high-risk early-stage triple-negative breast cancer (TNBC) in combination with chemotherapy as neoadjuvant treatment, and then continued as monotherapy as adjuvant treatment after surgery CNW Group
Apr-15-22 09:58AM	'Wonder Angie' Enlists Her 'Super Friends' to Fight Oral Cavity Cancer News Direct
07:33AM	3 Healthcare Stocks That Are Looking Even Healthier InvestorPlace
Apr-14-22 12:50PM	Is Merck & Co., Inc.'s (NYSE:MRK) Stock's Recent Performance Being Led By Its Attractive Financial Prospects? Simply Wall St.
06:45AM	Merck Announces U.S. FDA has Granted Breakthrough Therapy Designation for V116, the Companys Investigational 21-Valent Pneumococcal Conjugate Vaccine, for the Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Business Wire
05:55AM	The Petri Dish: Flagship appoints new CEO-partners, Ginkgo partners on another spinout American City Business Journals
Apr-13-22 09:27AM	Vaccines: Our History, Our Legacy News Direct
07:46AM	Japan-Based Shinogi's COVID-19 Drug Associated With Birth Defects: Bloomberg Benzinga
Apr-12-22 11:20AM	Gilead (GILD) Magrolimab Studies' Partial Clinical Hold Removed Zacks
Apr-11-22 07:01PM	Britain widens access to Pfizer's COVID antiviral drug through trial Reuters
05:45PM	Merck (MRK) Stock Moves -1.2%: What You Should Know Zacks
09:49AM	IMV's MVP-S Doublet Combo Therapy Shows Encouraging Anti Tumor Activity Benzinga
07:45AM	Health Canada Approves GARDASIL®9 (Human Papillomavirus 9-valent Vaccine, Recombinant) for the Prevention of Oropharyngeal and Other Head and Neck Cancers CNW Group
Apr-08-22 03:17PM	Iovance (IOVA) Stock Rallies 33% in a Month: Here's Why Zacks
09:28AM	Pharma Stock Roundup: PFE to Buy RSV Drugmaker, FDA Updates for NVS, MRK and RHHBY Zacks
06:45AM	Merck to Hold First-Quarter 2022 Sales and Earnings Conference Call April 28 Business Wire
Apr-07-22 10:38AM	The Zacks Analyst Blog Highlights Merck, CVS Health, American Tower, QUALCOMM and Analog Devices Zacks
Apr-06-22 12:39PM	Top Analyst Reports for Merck, CVS Health & American Tower Zacks
12:17PM	Iovance (IOVA) to Seek FDA Nod for Melanoma Therapy in August Zacks
09:47AM	Is it a Wise Decision to Invest in Merck and Co. (MRK)? Insider Monkey
09:26AM	Fighting COVID-19: 'An Intersection Between My Military and Civilian Careers' News Direct
Apr-05-22 05:45PM	Merck (MRK) Gains As Market Dips: What You Should Know Zacks
01:07PM	Merck: An Undervalued Stock With a Safe Yield GuruFocus.com
11:28AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick Zacks
11:23AM	What This Regulatory Approval Could Mean for Merck Motley Fool

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Garay Arpa	SVP Human Health Global Mktg.	May 04	Option Exercise	87.10	907	79,000	2,368	May 05 05:24 PM
Oosthuizen Johannes Jacobus	SVP, U.S. Market	May 04	Option Exercise	87.10	907	79,000	14,961	May 05 05:27 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 04	Option Exercise	87.10	949	82,658	41,429	May 05 05:19 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 04	Option Exercise	87.10	885	77,084	15,775	May 05 05:07 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 04	Option Exercise	87.10	813	70,812	3,943	May 05 05:04 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 03	Option Exercise	87.65	452	39,618	3,285	May 04 05:58 PM
Litchfield Caroline	EVP & CFO	May 03	Option Exercise	87.65	773	67,753	27,799	May 04 05:54 PM
Li Dean Y	Executive VP & President, MRL	May 03	Option Exercise	87.65	773	67,753	16,839	May 04 05:50 PM
Williams David Michael	EVP,Chief Info&Digital Officer	May 03	Option Exercise	87.65	427	37,427	9,410	May 04 05:44 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 03	Option Exercise	87.65	902	79,060	40,789	May 04 05:37 PM
Oosthuizen Johannes Jacobus	SVP, U.S. Market	May 03	Option Exercise	87.65	773	67,753	14,435	May 04 05:30 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 03	Option Exercise	87.65	773	67,753	15,271	May 04 04:53 PM
Garay Arpa	SVP Human Health Global Mktg.	May 03	Option Exercise	87.65	773	67,753	1,682	May 04 04:45 PM
Garay Arpa	SVP Human Health Global Mktg.	May 03	Option Exercise	87.65	773	67,753	1,682	May 04 04:44 PM
LeCointe-Cephas Lisa	SVP Chief Ethics & Com Officer	May 01	Option Exercise	88.69	640	56,762	3,053	May 03 04:25 PM
Williams David Michael	EVP,Chief Info&Digital Officer	May 01	Option Exercise	88.69	577	51,174	9,181	May 03 04:19 PM
Li Dean Y	Executive VP & President, MRL	May 01	Option Exercise	88.69	1,061	94,100	16,589	May 03 04:21 PM
Litchfield Caroline	EVP & CFO	May 01	Option Exercise	88.69	866	76,806	27,453	May 03 04:22 PM
Karachun Rita A	Sr. VP Fince-Global Controller	May 01	Option Exercise	88.69	928	82,304	40,205	May 03 04:17 PM
Oosthuizen Johannes Jacobus	SVP, U.S. Market	May 01	Option Exercise	88.69	866	76,806	14,089	May 03 04:16 PM
Klobuchar Michael A	EVP - Chief Strategy Officer	May 01	Option Exercise	88.69	866	76,806	14,925	May 03 04:13 PM
Garay Arpa	SVP Human Health Global Mktg.	May 01	Option Exercise	88.69	866	76,806	1,156	May 03 04:11 PM
Williams David Michael	EVP,Chief Info&Digital Officer	Feb 10	Option Exercise	76.53	1,202	91,989	7,421	Feb 14 11:13 AM
FRAZIER KENNETH C	Executive Chair	Nov 09	Option Exercise	0.00	663,881	0	1,250,676	Nov 10 04:06 PM
FRAZIER KENNETH C	Executive Chair	Nov 09	Sale	82.26	663,881	54,611,362	586,795	Nov 10 04:06 PM
Litchfield Caroline	EVP & CFO	Nov 04	Option Exercise	0.00	22,683	0	42,449	Nov 05 04:22 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Nov 04	Option Exercise	0.00	29,782	0	146,712	Nov 05 04:24 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Nov 04	Sale	90.40	29,782	2,692,299	116,930	Nov 05 04:24 PM
Litchfield Caroline	EVP & CFO	Nov 04	Sale	91.00	18,335	1,668,503	24,114	Nov 05 04:22 PM
Karachun Rita A	Sr. VP Fince-Global Controller	Nov 03	Option Exercise	0.00	25,000	0	60,799	Nov 04 04:19 PM
Karachun Rita A	Sr. VP Fince-Global Controller	Nov 03	Sale	88.45	25,000	2,211,215	35,799	Nov 04 04:19 PM
Clyburn Frank	EVP & Pres ? Human Health	Nov 01	Option Exercise	0.00	39,762	0	136,857	Nov 02 06:16 PM
Gerberding Julie L.	EVP, Chief Patient Officer	Nov 01	Option Exercise	0.00	96,270	0	135,432	Nov 03 04:11 PM
Gerberding Julie L.	EVP, Chief Patient Officer	Nov 01	Sale	87.91	96,270	8,462,682	39,162	Nov 03 04:11 PM
Clyburn Frank	EVP & Pres ? Human Health	Nov 01	Sale	87.87	39,762	3,493,879	97,095	Nov 02 06:16 PM
Clyburn Frank	EVP & Pres ? Human Health	Oct 30	Option Exercise	88.05	2,358	207,622	98,257	Nov 02 06:16 PM
MIZELL STEVEN	EVP, Chief HR Officer	Oct 30	Option Exercise	88.05	4,715	415,156	27,896	Nov 02 06:11 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Oct 29	Option Exercise	0.00	135,405	0	252,335	Nov 02 06:12 PM
Chattopadhyay Sanat	Exe V-P & Pres. MMD	Oct 29	Option Exercise	0.00	24,619	0	117,764	Nov 02 06:14 PM
DeLuca Richard R.	EVP&Pres, Merck Animal Heallth	Oct 29	Sale	87.56	135,405	11,856,265	116,930	Nov 02 06:12 PM
Chattopadhyay Sanat	Exe V-P & Pres. MMD	Oct 29	Sale	87.32	24,619	2,149,731	93,145	Nov 02 06:14 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience